About the Authors
- Rolando Pajon
-
Affiliation Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute, Oakland, California, United States of America
- Andrew M. Fergus
-
Affiliation Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute, Oakland, California, United States of America
- Oliver Koeberling
-
Current address: Novartis Vaccine Institute for Global Health, Siena, Italy
Affiliation Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute, Oakland, California, United States of America
- Dominique A. Caugant
-
Affiliation Department of Bacteriology and Immunology, Norwegian Institute of Public Health, and Department of Community Medicine, University of Oslo, Oslo, Norway
- Dan M. Granoff
-
* E-mail: dgranoff@chori.org
Affiliation Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute, Oakland, California, United States of America
Competing Interests
Dan M. Granoff is principal investigator of laboratory research conducted on behalf of Children's Hospital Oakland Research Institute that is funded by grants from Novartis Vaccines and Diagnostics, and Sanofi Pasteur. He also holds a paid consultancy from Novartis. Dominique A. Caugant has performed research at the Norwegian Institute of Public Health funded by Novartis, Wyeth and Sanofi Pasteur. Oliver Koeberling is currently an employee of Novartis Vaccine Institute for Global Health, Siena Italy. Rolando Pajon and Andrew M. Fergus declare no conflicts.
Author Contributions
Conceived and designed the experiments: RP DAC DMG. Performed the experiments: RP AMF OK. Analyzed the data: RP DMG. Contributed reagents/materials/analysis tools: DAC. Wrote the paper: RP DMG.